1.Basic Information
Product name |
5-Methoxytryptamine |
CAS No |
608-07-1 |
Appearance |
White crystal powder |
Molecular formula |
C11H14N2O |
Molecular weight |
190.24 |
boiling point |
325.75°C |
melting point |
121-123 °C |
refractive index |
1.5700 |
density |
1.0815 |
Storage conditions |
2-8°C |
Applications |
Melatonin Intermediate |
2.COA:
CERTIFICATE OF ANALYSIS
Product name |
5-Methoxytryptamine |
Country of Origin |
China |
Batch Size |
500KG |
Batch Number |
20220508 |
Manufacture Date |
May 8, 2022 |
Expiry Date |
May 7, 2023 |
ITEM |
STANDARD |
RESULT |
Identification |
Positive reaction |
Conform |
Loss on drying |
0.5% MAX |
0.04% |
Sulphated Ash |
0.5% MAX |
0.06% |
Color test |
0.5% Reference solution |
conform |
Heavy metal |
20PPM MAX |
conform |
Assay(HPLC) |
98.0% MIN |
99.12% |
Conclusion: Comply with the requirements of enterprise standard.
3.Source
5-Methoxytryptamine is a tryptamine derivative closely related to the neurotransmitters serotonin and melatonin. 5-Methoxytryptamine has been shown to occur naturally in the body at low levels. It is biosynthesized by deacetylation of melatonin in the pineal gland.
4.Function
5-Methoxytryptamine is a tryptamine derivative that is closely related to the neurotransmitters melatonin and serotonin. It acts as a full agonist at the 5-HT1, 5-HT2, 5-HT4, 5-HT6 and 5-HT7 receptors, but has no affinity for the 5-HT3 receptor. It is a full agonist at the 5-HT1, 5-HT2, 5-HT4, 5-HT6 and 5-HT7 receptors.
5.Application
The protective effect of 5-methoxytryptamine, a metabolite of melatonin, in human keratinocytes against ultraviolet B (UVB) has been investigated. 5-Methoxytryptamine as an agonist has been used in pharmacological studies of serotonin-1 receptors.
Reactants for the preparation of:
1.Carboline disaccharide domain of shishijimicin A
2.Melatonin analogs for lowering intraocular pressure
3.5-HT4 receptor ligands
4.Inhibitors of sortase A and isocitrate lyase
5.Therapeutic agents for the treatment of ischemia/reperfusion (I/R) injury
6.Agents used to treat human papillomavirus infection
7.Manzamine analogs to control neuroinflammation and brain infections
8.Inhibitors of pro-inflammatory cytokines
Tacrine-melatonin hybrids as multifunctional drugs for Alzheimer's disease